What panthenol is

Panthenol is the alcohol corresponding to pantothenic acid (vitamin B5). It is not itself a vitamin but a provitamin: enzymes in the skin oxidise it to pantothenic acid, which then feeds coenzyme A (CoA) synthesis. CoA is a central cofactor in cellular energy metabolism and lipid synthesis, which is why panthenol has always been positioned as a supply ingredient rather than an active drug — it provides raw material the skin uses daily, not an external intervention.

Three grades are common on the market: D-panthenol (dexpanthenol, CAS 81-13-0), DL-panthenol (racemic, CAS 16485-10-2) and panthenol solution (commonly 75% or 50%). The D-form is the natural configuration, generally regarded as more bioavailable and priced accordingly; the DL-form is a racemic mixture that costs less and performs adequately in most formulas. Always check the INCI name PANTHENOL and the CAS number to confirm configuration — do not let a DL grade be quoted as D. Note also that panthenol as a pure substance is a highly viscous clear liquid or white crystalline powder, and the 75% aqueous solution is easier to dose on the line.

Its physico-chemical profile in short: water-soluble, colourless to faintly yellow, very low odour, moderately heat-sensitive (prolonged heat degrades it), most stable from mildly acidic to neutral. For the formulator that means it fits almost any aqueous system without adding colour or odour load, but must not sit at high temperature for long. One advantage is often overlooked: it takes the edge off discomfort from other, more aggressive ingredients, which is why it shows up as a buffer in formulas containing acids, alcohols or high-loading actives.

Ingredient fact box

How it works, plainly

Panthenol works on three levels, outside in: it binds water on the surface, softens the corneum, and supplies raw material within the skin. The first two are felt immediately; the third is what long-term use is for.

• Level one: humectancy. Panthenol carries several hydroxyl groups that bind water and hold it in the corneum, placing it in the same humectant camp as glycerin and sodium hyaluronate. The difference is its much smaller molecule (≈205 Da), which feels less tacky and lighter than glycerin — one reason it is preferred on thin skin such as the eye area.
• Level two: emollience and softening. It does more than bind water: it wets and softens dry corneocytes so a flaky, rough surface looks smoother. This is the main source of the immediate visual improvement — dryness lines look shallower once the corneum is hydrated, which is an appearance-level change, not a structural one.
• Level three: conversion to pantothenic acid. Inside the skin, panthenol is oxidised to pantothenic acid and enters the coenzyme A pathway, taking part in epidermal lipid synthesis and day-to-day barrier maintenance. This is the source of long-term support, and the logic behind pairing it with barrier lipids such as ceramides and cholesterol.
• A note on how to position soothing. Panthenol is widely used as a soothing adjunct, often alongside centella, allantoin or bisabolol; its role is to take the edge off discomfort and raise overall formula tolerance, not to treat a skin condition. Claims should read "helps improve the look of dryness and roughness around the eyes" or "boosts the feel of hydration" — never "soothes inflammation", "treats dermatitis" or "medical".
• An honest note on evidence strength. Panthenol has a long history of cosmetic use and a solid safety data set, but eye-area-specific, large-sample controlled human studies are likewise limited, with most findings coming from general skin sites and in-vitro work. Verify on PubMed with "panthenol", "dexpanthenol" and "skin barrier".

A blunt note for sourcing: panthenol does not work as a headline active — its value is lifting the skin feel and tolerance of the whole formula at very low cost. The right place for it in a brief is "hydration and soothing base", leaving the headline benefit to peptides, retinoids or brightening actives. That saves money and makes the difference easier for consumers to feel.

Best-fitting formats

Use level and formulation notes (verify by bench trial)

Common reference level: a common reference range in cosmetics is ≈0.5%–5%, with eye care formulas typically landing at 1%–3%. Going beyond that rarely brings linear benefit and adds tackiness and cost. The actual level is set on the bench by format, compatibility, target-market rules and stability data, converted against the assay on the supplier COA (a 75% solution must be dosed on active content).

• pH is constraint #1. Keep it at 5.0–7.0. Panthenol hydrolyses under both strongly acidic and strongly alkaline conditions (the amide bond in its structure is pH-sensitive), so combining it with high-level AHAs, salicylic acid or other low-pH systems needs separate verification — adjust the addition stage, or split timing or lines where needed.
• Temperature is constraint #2. Add to the water phase below 40 °C and avoid prolonged or repeated heating; use low-temperature addition in emulsified systems.
• Dosing form affects handling. The 75% solution has moderate viscosity and meters easily; the pure grade is viscous, so pre-warm or pre-dissolve it into a stock solution to avoid wall cling and dosing error.
• Compatibility with preservation. Panthenol is not a preservative; high-water-activity systems still need routine preservative efficacy testing. Do not lower preservation standards on the grounds that an ingredient is mild.
• Managing tackiness in combination. Stacking it with high-molecular-weight sodium hyaluronate or xanthan gum can produce pilling or a sticky feel — balance skin feel through polymer selection and ratio.
• Raw-material spec. State configuration (D or DL), assay, optical rotation, heavy-metal and microbial limits, and require a COA plus stability data.
• Stability protocol. 40 °C for 3 months plus freeze–thaw, with panthenol retention measured as one of the release criteria; also watch odour and viscosity drift.

The figures above are common reference levels for eye care formulas; the actual use level is set by the formulation engineer based on dosage form, compatibility and target-market rules. Permitted use conditions, limits and labelling requirements differ by market — complete a compliance review for each destination before shipment. All descriptions here are general cosmetic applications and appearance or skin-feel statements, not medical advice or efficacy guarantees.

Compliance and market notes (verify per target market)

• China: first verify listing status and historical maximum use level in the Inventory of Existing Cosmetic Ingredients in China (2021 edition) (per the latest NMPA announcement), then complete filing under the Cosmetic Supervision and Administration Regulation. Panthenol is a long-established raw material with a solid safety data set, so compliance risk is comparatively low; where claims such as "moisturising" or "soothing" appear in the efficacy-claim evaluation rules, the corresponding evaluation must be completed and its summary published.
• EU (EC) No 1223/2009: declare the ingredient and impurity profile accurately in the CPNP notification, PIF and CPSR, and complete the safety assessment; claims must meet the (EU) No 655/2013 common criteria. Panthenol is widely used in EU cosmetics, but the safety assessment must still be done for the actual formula — long history is not a substitute.
• US MoCRA (2022): facility registration, product listing, safety substantiation, adverse-event reporting and record-keeping apply, with labelling under the FD&C Act and relevant 21 CFR provisions. Cosmetic ingredients and finished products generally do not undergo pre-market approval — never write "FDA approved".
• Claim red lines (all markets): never use medical or absolute wording such as "treats", "anti-inflammatory", "medical", "repairs damaged skin" or "cures dryness". On the Chinese site use appearance and skin-feel wording such as "帮助改善眼周干燥与粗糙外观", "提升水润感" and "缓和不适感".
• Japan / Korea / Middle East: each follows its own cosmetic or quasi-drug pathway with different boundaries — verify per target market, and confirm listing status and label format before export.
• Recommended action: at project kick-off, give your regulatory adviser four items — ingredient, use level, dosage form and claim copy — for one upfront review; where panthenol sits alongside low-pH actives, submit pH and hydrolysis risk for assessment at the same time.

Ingredient pairings

• Panthenol + sodium hyaluronate (0.1%–0.5%): the most basic "draw water plus seal water" pair in hydration. Sodium hyaluronate binds water into a film, panthenol softens and supplies; the skin feel is complementary and the pH windows align.
• Panthenol + ceramides + cholesterol: the three-part barrier-support logic. Panthenol supplies metabolic raw material while ceramides and cholesterol replenish intercellular lipids — suited to dry, sensitive eye-area positioning.
• Panthenol + centella extract + allantoin: a common soothing base used to take the edge off high-loading actives, and a mainstream soothing platform for the eye patch category.
• Panthenol + niacinamide (2%–5%): hydration and soothing plus even tone; close pH windows and good compatibility make this a fit for everyday multi-benefit eye creams.
• Panthenol + squalane (3%–10%): hydrophilic water capture plus oil-phase occlusion closes the hydration loop — good for cold, dry seasons or dry eye areas.
• Use with care: combining with high-level AHAs/BHAs or other low-pH systems requires hydrolysis verification — split timing or lines. Strongly alkaline systems are likewise a poor long-term match. Watch for pilling and tackiness when stacked with high-viscosity polymers, and avoid prolonged high-temperature processing.

Formulation pairing cards

FAQ

Image briefs